CNS Pharmaceuticals, Inc. (CNSP) Financials

CNSP Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 21.9 million 3.7 million
March 31, 2026 4.7 million 4.6 million
Dec. 31, 2025 8.6 million 4.1 million
Sept. 30, 2025 11.9 million 2.0 million

CNSP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.5 million 2445
March 31, 2026 -4.7 million 2555
Dec. 31, 2025 -3.1 million 85068
Sept. 30, 2025 -2.2 million 18452

CNSP Net Income

No data available :(

CNSP Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 20.0 million - -
March 31, 2026 3.0 million - -
Dec. 31, 2025 7.2 million - -
Sept. 30, 2025 9.9 million - -

CNSP Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 6.8 million
March 31, 2026 676172
Dec. 31, 2025 443369
Sept. 30, 2025 558868

CNSP Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 3821 1.2 million 1.5 million -
March 31, 2026 6179 3.5 million 1.4 million -
Dec. 31, 2025 18175 3.2 million 2.8 million -
Sept. 30, 2025 - 2.2 million 1.1 million -

CNSP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 1868
Dec. 31, 2025 - -2898
Sept. 30, 2025 - 697

CNSP

Price: $5.34

52 week price:
1.90
10.59

Earnings Per Share: -15.39 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 89600

Market Capitalization: 7.8 million

Links: